Emerging links between gut dysbiosis, aryl hydrocarbon receptor activation, and Parkinson’s disease
Parkinson’s disease (PD) is the second most common progressive neurodegenerative disease worldwide, inflicting health and economic burden on…
Could GLP-1 Drugs Reduce Breast Cancer Risk?
GLP-1 medications are best known for their use in obesity and diabetes treatment, but new research suggests they may have potential in cancer prevention. As reported by The…
Metab8D: a metabolic regulome network from multiomics and machine learning
To explore multiomic regulation of the metabolome, we used machine learning to predict metabolomic variation across ~1000 different…